Stephen Dilly
Chief Executive Officer at CODEXIS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Stephen George Dilly is currently the President, CEO & Independent Director at Codexis, Inc. He is also the Chairman at Cognoa, Inc., a Director at Adjuvance Technologies, Inc., and a Director at ImmunoMolecular Therapeutics, Inc. Previously, Dr. Dilly held positions as the President, Chief Executive Officer & Director at Sierra Oncology, Inc. from 2020 to 2022, President, Chief Executive Officer & Director at PhotoThera, Inc. from 2011 to 2012, President, Chief Executive Officer & Director at APT Pharmaceuticals, Inc. from 2006 to 2011, President, Chief Executive Officer & Director at Aimmune Therapeutics, Inc. from 2014 to 2018, and as an Independent Director at Sangamo Therapeutics, Inc. from 2010 to 2020.
He also served as a Vice President-Development Sciences at Genentech, Inc. from 1998 to 2003 and as the Chief Medical Officer & SVP-Development at CHIRON Biopharmaceuticals from 2003 to 2006.
Additionally, he was a Director at Avigen, Inc. from 2007 to 2009 and an Executive Chairman at DNAtrix, Inc. Dr. Dilly obtained a doctorate degree from the University of London in 1982 and another doctorate degree from the University of London in 1988.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CODEXIS, INC.
0.83% | 2023-12-31 | 582,303 ( 0.83% ) | 2 M $ | 2024-03-30 |
Stephen Dilly active positions
| Companies | Position | Start |
|---|---|---|
| CODEXIS, INC. | Chief Executive Officer | 2022-08-08 |
Adjuvance Technologies, Inc.
 Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Director/Board Member | - |
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Chairman | - |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | Director/Board Member | 2020-02-06 |
Former positions of Stephen Dilly
| Companies | Position | End |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Chief Executive Officer | 2022-06-30 |
| SANGAMO THERAPEUTICS, INC. | Director/Board Member | 2020-09-29 |
| AIMMUNE THERAPEUTICS, INC. | Chief Executive Officer | 2018-06-18 |
PhotoThera, Inc.
 PhotoThera, Inc. Medical SpecialtiesHealth Technology PhotoThera, Inc. (Carlsbad, CA) is a privately-held medical device company that was founded by Jackson Streeter, MD. The Company is developing proprietary, noninvasive laser energy therapies that may revolutionize the clinical care and management of ischemic stroke, traumatic brain injury, global ischemia, and other conditions characterized by disturbances in cellular metabolic function. The Company's initial product, the NeuroThera Laser System, will focus on the Transcranial Laser Therapy (TLT) of acute ischemic stroke. Estimates show that, in the United States, there are more than 600,000 ischemic strokes annually, and that stroke is the leading cause of serious long-term disability. | Chief Executive Officer | 2012-11-30 |
APT Pharmaceuticals, Inc.
 APT Pharmaceuticals, Inc. BiotechnologyHealth Technology APT Pharmaceuticals, Inc. operated as a drug development company. The company was founded on December 15, 1999 and was headquartered in Burlingame, CA. | Chief Executive Officer | 2011-11-30 |
Training of Stephen Dilly
| University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| CODEXIS, INC. | Process Industries |
| Private companies | 12 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
PhotoThera, Inc.
PhotoThera, Inc. Medical SpecialtiesHealth Technology PhotoThera, Inc. (Carlsbad, CA) is a privately-held medical device company that was founded by Jackson Streeter, MD. The Company is developing proprietary, noninvasive laser energy therapies that may revolutionize the clinical care and management of ischemic stroke, traumatic brain injury, global ischemia, and other conditions characterized by disturbances in cellular metabolic function. The Company's initial product, the NeuroThera Laser System, will focus on the Transcranial Laser Therapy (TLT) of acute ischemic stroke. Estimates show that, in the United States, there are more than 600,000 ischemic strokes annually, and that stroke is the leading cause of serious long-term disability. | Health Technology |
APT Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc. BiotechnologyHealth Technology APT Pharmaceuticals, Inc. operated as a drug development company. The company was founded on December 15, 1999 and was headquartered in Burlingame, CA. | Health Technology |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Technology |
Physic Ventures LLC
 Physic Ventures LLC Investment ManagersFinance Physic Ventures LLC (Physic Ventures) is a venture capital firm founded in 2006 by Dion Madsen and Will B.Rosenzweig. The firm is headquartered in San Francisco, California. | Finance |
| CHIRON Biopharmaceuticals | |
Adjuvance Technologies, Inc.
Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | Health Technology |
Cognoa, Inc.
Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Health Services |
- Stock Market
- Insiders
- Stephen Dilly
